Condition
Multiomics Analysis
Total Trials
4
Recruiting
0
Active
0
Completed
1
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 4 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 1 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
Trial Status
Not Yet Recruiting3
Completed1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 1 completed trials
Clinical Trials (4)
Showing 4 of 4 trials
NCT07380997Not Yet Recruiting
Multi-Omics Integrative Analysis of Serum and Sputum to Uncover Key Determinants of Prognosis in Patients With ARDS
NCT06376773Completed
Neoadjuvant Treatment Based on Gastric Cancer Molecular Subtyping.
NCT06007300Not Yet Recruiting
A Multiomics Study Based on the Dynamic Evolution of Endometrial Carcinogenesis
NCT05985941Not Yet Recruiting
Prospective Multi-omics Observational Study of Gynecological Rare Pathological Tumors
Showing all 4 trials